Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Yaytrade extends its agreement with Filippa K

Ytrade Group AB (publ) (“Yaytrade”) and Filippa K AB (“Filippa K”) have come to an extension agreement for international sales of the Filippa K SS21 Sample Sale. The agreement pertains to the markets Filippa K operates in and includes a starting point of approximately 2,000 articles. “We are incredibly pleased to have gained the continuing confidence of Filippa K and look forward to driving the digital sales of this season’s samples. That we are able to do so on an international basis demonstrates the strength of the Yaytrade marketplace and is proof positive that we are taking steps

Lower sales due to the pandemic but new rights issue secures continued international expansion

First quarter                  · Net sales reached SEK 17.0 (26.8) million. · Result after tax came in at SEK -8.9 (0.7) million. · Earnings per share, basic and diluted, were SEK -0.06 (0.01). · Cash and cash equivalents were SEK 21.4 (33.9) million. Significant events in Q1 · Enzymatica’s sales during the quarter declined compared with the corresponding period in 2020 due to the effects of the pandemic, which essentially reduced the cold remedy market by 50 percent, both in Sweden and in other markets.  · Enzymatica announced on March 22 that sales for 2021

HKScan promoting the future of responsible food production with the Science Based Targets initiative

HKScan continues its ambitious climate work and is committed to the international Science Based Targets initiative (SBT). Setting science-based climate targets contributes to HKScan’s Zero Carbon climate plan and supports the company’s journey towards carbon-neutral food production.HKScan Oyj, media release 29 April 2021HKScan will develop climate targets covering its food chain for Science Based Targets initiative’s official validation. The company has already set a goal of carbon neutrality of its own industrial production by the end of 2025 and carbon neutrality of the entire food

Interim Report 1 January – 31 March 2021

”Whilst this is the best quarter in the history of Episurf, I know that once the Covid-19 pandemic has subsided, we have much more to look forward to. Of course, we recognise that we are at the start of our financial journey. But showing a strong increase in gross order intake, a growing number of surgeons using the Episealer®, an improving annual run-rate indicating continued repeat business, and a strong growth in the number of countries in which we are active, during such a challenging quarter as the first quarter of 2021, gives me a lot of confidence for the future”, says Pål Ryfors,

NextCell Pharma publishes Interim Report 2 2020/2021

NextCell Pharma AB (publ) (NXTCL or NextCell) publishes its Interim Report 2 for the period September 1, 2020 - February 28, 2021 The report is available on the company’s website: https://www.nextcellpharma.com/en/investors#financial-report NextCells share is traded on Nasdaq First North Growth Market under the ticker "NXTCL". The amount in brackets refers to the corresponding period in the previous year.Second quarter (2020-12-01 until 2021-02-28) · Operating income amounted to SEK 1 007 846 (1 364 645). · Operating result amounted to SEK -8 148 299 (-4 228 449). · Earnings

Sara Nilsson appointed as new CFO of Vitec Software Group AB (publ)

Sara Nilsson has been appointed Chief Financial Officer, CFO, of Vitec. She succeeds Olle Backman who assumed the position as CEO.Sara Nilsson has extensive experience within Vitec and has most recently been Manager Group Finance. ”I am very happy to be able to present Sara as our new CFO. Sara has worked in many different roles within Vitec in recent years and knows both the corporate culture and the organization well. She has previous experience from both large and small organizations and the auditing industry,” says Olle Backman CEO of Vitec Software Group. Sara Nilsson holds a

Interim report 1 January – 31 March 2021

In March 2021, we passed the one-year milestone for corona virus and a pandemic that has had a major impact on society, our way of life and human health. It has also entailed depressing conditions for Moment Group and the industry in which we do business, something that is clearly reflected in our sales for the past 12 months, which totalled SEK 113 million. This is a decrease of SEK 863 million (88%) compared to the corresponding period one year earlier. For management, the first quarter was characterised by putting in place the last components of the financial solution reached on 27

Scandinavian Enviro Systems (publ) publishes Annual Report 2020

Scandinavian Enviro Systems’ Annual Report for 2020 is as of today, Thursday April 29 2021, available on the company’s website https://www.envirosystems.se/en/investor/financial-information/.N.B. The English text is an in-house translation of the original Swedish text. Should there be any disparities between the Swedish and the English text, the Swedish text shall prevail. Mangold Fondkommission AB, +46 (0)8 503 01 550, ca@mangold.se, is Enviro’s Certified Adviser on Nasdaq First North Growth Market Stockholm. For further information, please contact: Thomas Sörensson, CEO of Enviro,

Interim report January to March 2021

Press release Stockholm, Sweden April 29, 2021   Strong start of the year First quarter 2021 · Net sales decreased during the first quarter by 5,7% to 74,4 MSEK (78,9) · Adjusted EBITDA increased during the first quarter by 43,3% to 9,9 MSEK (6,9), corresponding to an adjusted EBITDA margin by 13,3% (8,8) · Operating profit/loss was 4,8 MSEK (-3,8) which correspond to operating margin of 6,5% (-4,9) · Profit for the period was 4,5 MSEK (-8,7) · Result per share was 0,01 (-0,02) · Cash flow from operating activities for the period was 3,4 MSEK (2,5) Subsequent

Interim Report 1 January - 31 March 2021

IMPROVED EBITA MARGIN AND CONDITIONS FOR GROWTHFIRST QUARTER SUMMARY, JANUARY–MARCH 2021• Net sales decreased by 16 per cent to SEK 1,036 m (1,234), of which -17 per cent organic.  Currency-adjusted organic growth was -14 per cent.• EBITA was SEK 107 m (108), and the EBITA margin increased to 10.3 per cent (8.8).• Operating profit was SEK 73 m (77), with an operating margin of 7.0 per cent (6.2).• Profit after tax was SEK 54 m (57).• Earnings per share were SEK 1.62 (1.71).• Cash flow from operating activities decreased to SEK 150 m (276).• Agreement signed to acquire S-

Interim report January – March 2021

NET ASSET VALUE AND THE LATOUR SHARE · The net asset value rose to SEK 166 per share, compared with SEK 153 per share at the start of the year. This is an increase of 8.1 per cent. By comparison, the Stockholm Stock Exchange's Total Return Index (SIXRX) increased by 14.3 per cent. The net asset value amounted to SEK 173 per share at 28 April.[1 ] · The total return on the Latour share was 13.3 per cent during the period measured against the SIXRX, which rose 14.3 per cent. INDUSTRIAL OPERATIONS · The industrial operations' order intake rose 14 per cent to SEK 4,537 m (3,996

Save the date: Epiroc to host Capital Markets Day on December 1

Stockholm, Sweden: Epiroc, a leading productivity and sustainability partner for the mining and infrastructure industries, will host an online Capital Markets Day for institutional investors, analysts and financial media on December 1, 2021, at 15:00 CET.The purpose of the 2.5-hour event is to give an update on Epiroc’s strategy for profitable growth. Topics such as innovation, aftermarket, operational excellence and sustainability will be covered. Participating from Epiroc will be Helena Hedblom, President and CEO; Anders Lindén, CFO; and other managers. Instructions on how to register

Annual Report 2020: Scandion Oncology is setting the pace for the future

Scandion Oncology’s Annual Report 2020 has now been published and is available on the company’s website (www.scandiononcology.com ).Bo Rode Hansen, President & CEO, Scandion Oncology A/S comments: “In 2020, we met major catalysts with initiation of clinical trials, securing financing, preparing for list change to Nasdaq and internationalization. We saw the first signs of activity with SCO-101 and FOLFIRI in patients. This enabled the company to secure a strong financial position and start building the organization for the future.  In

Nightingale Health signed service agreement for health and well-being services in Japan

Company release Inside information 29 April 2021 at 9:15 a.m. (Finnish time) Nightingale Health Plc, Nightingale Health Japan KK, a fully owned subsidiary of Nightingale Health Plc (together “Nightingale”), and Welltus Inc., a fully owned subsidiary of Mitsui & Co. Ltd have entered into a service agreement to sell health and well-being services in the Japanese market. With the agreement, Mitsui will start selling services that utilize Nightingale’s blood analysis technology, via its subsidiary Welltus. Welltus is building its wellness and prevention platform in the Japanese

Annual Report 2020

SGL TransGroup International A/S (SGL Group) has today published the annual report 2020 SGLT Holding (SGLT Holding I LP) · For SGLT Holding, the 2020 revenue was USD 1.2 billion and Adjusted EBITDA excluding the impact of IFRS 16 leases was USD 50.4 million; compared to 2019 organic growth of 8% in revenue and 17% increase in Adjusted EBITDA despite disruptions from COVID-19 · The strong performance was derived through the strength of our entrepreneurial business model and the breadth and diversity of our customers and partners, combined with disciplined execution of COVID-19

Eficode wins two global Atlassian Partner of the Year awards 2020: in DevOps and in Services

Eficode has now earned the award in DevOps for three consecutive years Helsinki, April 28, 2021 - Atlassian today named Eficode, the leading DevOps company in Europe, the Atlassian Partner of the Year 2020: DevOps. Simultaneously Atlassian named Riada - Now part of Eficode, Atlassian Partner of the Year 2020: Services. In 2020, Eficode and Riada have continued to grow Atlassian services’ adoption, both as managed services, and through professional services. They also achieved major customer milestones with Jira Align and Jira Service Management. Throughout 2020 they helped a

Read original

SpareBank 1 SR-Bank ASA: Annual General Meeting held

The Annual General Meeting of SpareBank 1 SR-Bank ASA was held on 28 April 2021. Meeting was held digitally due to COVID-19. All items on the agenda were adopted as proposed, cf. the notice published on 7 April 2021. The minutes of the Annual General Meeting is enclosed. The information is subject to the disclosure requirements set out in section 5-12 of the Norwegian Securities Trading Act. Contact:Inge Reinertsen, CFO, Tel. +47 909 95 033

Axolot Solutions Holding AB (publ) - Interim report January-March 2021

The operations are in all aspects preparing in order to be well positioned as the society opens up again after the pandemic.Summary of the first quarter 2021 Financially · Net sales amounted to 483 tSEK (725 tSEK for the corresponding quarter in 2020), which in principal refers to trial runs.  · Other revenues were 190 tSEK (446), which relates to state subsidies and support.  · Earnings before interest and tax became -4 445 tSEK (-6 237), where the result improvement relates to restructuring measures taken one year ago, due to the pandemic.  · Net earnings per share

Q1 2021 Trading Update and board change

This announcement contains inside information International Personal Finance Q1 2021 trading update and board change 29 April 2021 International Personal Finance plc specialises in providing unsecured consumer credit to 1.7 million customers across 11 markets.  We operate the world's largest home credit business and a successful fintech business. Highlights · Robust Q1 trading performance delivered as we rebuild the business · Good progress in credit issued with YoY contraction moderating to 18% in Q1 2021 compared to 31% in Q4 2020  · Continued strong

Nel ASA: Invitation to presentation of Q1 2021 results

(Oslo, 29 April 2021) Nel ASA (Nel) will announce its first quarter 2021 report on Tuesday 4 May at 07:00 CET and will host a virtual presentation at 08:00 CET. Due to Covid-19 restrictions, physical participation at the results presentation will not be possible. The presentation will be held in English. The presentation will be broadcasted live at www.nelhydrogen.com and can also be streamed at https://channel.royalcast.com/landingpage/hegnarmedia/20210504_1/. The presentation will be followed by Q&A based on submitted questions during the call. The report and presentation will be

Inzile AB (publ) Interim Report 1 January – 31 Mars 2021

First quarter 2021 in brief · Establishment of a sales company in Norway launches international expansion · Evaluation of production in Spain initiated · Private placement provided the company with MSEK 127 First quarter 2021 in numbers · Net sales amounted to MSEK 1,1 (0) · Operating profit (EBIT) amounted to MSEK -19,3 (-10.1) · The result for the period amounted to MSEK -19,4 (-10.1) · Earnings per share before and after dilution amounted to SEK -1,01 (-0.81) Events during the period Inzile has launched its international expansion by establishing a sales

Interim Report – 3 months 1 January-31 March 2021

· Revenue amounted to MSEK 2,325 (1,539), with the change compared with the previous year primarily attributable to the acquisition of Swedol. Compared with revenue for the corresponding quarter in the preceding year including Swedol (MSEK 2,368), revenue declined by 2 percent.* · EBITA amounted to MSEK 125 (91), corresponding to an EBITA margin of 5.4 percent (5.9). The change compared with the previous year is primarily attributable to the acquisition of Swedol. Compared with EBITA for the corresponding period in the previous year including Swedol (MSEK 134), EBITA declined by 7

There are no items matching the current filter
There are no more items matching the current filter
Back to top